Immunocore Hldgs Q3 EPS $(0.28) Misses $(0.10) Estimate, Sales $102.222M Miss $113.438M Estimate

Immunocore Hldgs (NASDAQ:IMCR) reported quarterly losses of $(0.28) per share which missed the analyst consensus estimate of $(0.10) by 180 percent. The company reported quarterly sales of $102.222 million which missed the analyst consensus estimate of $113.438 million by 9.89 percent. This is a 1.42 percent decrease over sales of $103.693 million the same period last year.